Content area

|
|

Tidlig opsporing og diagnostik af prostatakræft

Forfatter(e)
Michael Borre Urinvejskirurgi, Aarhus Universitetshospital

Ugeskr Læger 2018;180:V06180418
Reference: 
Ugeskr Læger 2018;180:V06180418
Blad nummer: 
Sidetal: 

Michael Borre:

Prostate cancer – screening and early detection

Ugeskr Læger 2018;180:V06180418

The primary objectives of population screening for prostate cancer (PCa) are a reduction in mortality due to PCa and a maintained quality of life. Currently, screening for PCa is one of the most controversial topics in the urological literature; and findings have led to strong advice against systematic population-based screening. PCa is usually suspected based on palpation and/or prostate specific antigen levels, and a definitive diagnosis depends on histopathological verification in biopsy cores. Multiparametric MRI is increasingly performed before prostate biopsy.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Knud Christian Christensen | 10/12
1 Kommentar
af Poul Henning Madsen | 10/12
2 kommentarer
af Bent Fabricius Stolberg | 10/12
4 kommentarer
af Niels Krintel Petersen | 09/12
2 kommentarer
af Julius Vindbjerg Nissen | 09/12
1 Kommentar
af Inger Struckmann | 09/12
1 Kommentar
af Birgitte Brandstrup | 09/12
1 Kommentar